Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
180.46
-5.70 (-3.06%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Revolution Medicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $263 | Buy | Maintains | $263 | +45.74% | Jul 11, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 10, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $205 → $235 | Buy | Maintains | $205 → $235 | +30.22% | Jul 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $195 | Buy | Reiterates | $195 | +8.06% | Jul 6, 2026 |
| UBS | UBS | Buy Reiterates $175 → $220 | Buy | Reiterates | $175 → $220 | +21.91% | Jul 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $185 → $215 | Buy | Maintains | $185 → $215 | +19.14% | Jul 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 3, 2026 |
| Needham | Needham | Buy Reiterates $183 → $235 | Buy | Reiterates | $183 → $235 | +30.22% | Jun 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.